SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹176 Cr | ₹123 Cr | ₹138 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹138 Cr |
How is Total Non-Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹176 Cr | 43.07 | |
| Mar2024 | ₹123 Cr | -11.15 | |
| Mar2023 | ₹138 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,422.9 Cr | -4% | 3.3% | -37.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹26,600.1 Cr | 5.3% | 0.9% | -28.6% | Stock Analytics | |
| SAGILITY INDIA | ₹23,795.2 Cr | 2.9% | -4.5% | 16.2% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹10,139.3 Cr | -2.3% | 0.4% | -4.3% | Stock Analytics | |
| JUST DIAL | ₹6,104.9 Cr | 0.6% | -2.3% | -33.8% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹3,719.5 Cr | 7% | -8.6% | -36.7% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -4% |
3.3% |
-37.1% |
| SENSEX | 0.1% |
0.9% |
4.5% |
You may also like the below Video Courses